Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
BioNTech SE is a biotechnology company focused on developing and commercializing innovative immunotherapies for cancer and infectious diseases. The company has a broad pipeline of investigational treatments, including mRNA-based therapies and other novel approaches, targeting various solid tumors and other serious conditions. BioNTech is a significant player in the field of cancer immunotherapy, with a strong emphasis on clinical development and advancing its diverse product candidates.
AI-generated summary. Not investment advice.